FOMAT

NASH- NCT06215716

A study exploring a possible new treatment for adults living with NASH or MASH and liver fibrosis.

Criteria & Qualifications:

Are between 18 and 80 years of age

Have been diagnosed with NASH or MASH with liver scarring

Have metabolic health conditions such as obesity, high blood pressure, high blood sugar, abnormal cholesterol, or type 2 diabetes

Compensation: Contact Us for more info